Comparative Analysis of Medical Device Regulatory Frameworks Across Countries

Regulatory frameworks for medical devices are continually evolving to keep pace with technological innovation, aiming to ensure safety and efficacy. However, regulatory requirements differ substantially across countries, creating challenges for manufacturers, regulators, and timely patient access to medical technologies. This study aims to comparatively analyze medical device regulatory frameworks across the 12 member countries of the International Medical Device Regulators Forum, as well as in Pakistan and Thailand.

A systematic search was conducted using PubMed and Scopus from inception to September 2025, supplemented by data from official national regulatory authority websites. Studies were selected based on their examination of regulatory frameworks, including structural components, required documentation, and associated challenges and benefits. Content analysis was applied to synthesize findings.

Of 755 identified records, 22 studies and 14 official regulatory websites met inclusion criteria. Definitions and classification systems varied, with 12 countries using a 4-tier model and 2 using a 3-tier classification. ISO 13485 certification was widely required for quality management system, whereas ISO 14155 was commonly mandated for clinical investigations. Key registration documents included technical dossiers, clinical evaluation reports, quality management system compliance evidence, and labeling. Approval timelines ranged from 3 to 24 months. Common challenges included centralized approval processes, regulatory complexity, and language translation barriers.

Despite harmonization efforts, significant variations in regulatory standards persist across countries. These differences may hinder timely and equitable access to medical devices. Greater alignment of regulatory practices could enhance global access to safe, effective, and innovative medical technologies.